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Abstract 
Obesity and sarcopenia combination, appropriately defined as sarcopenic obesity (SO), due to 
disproportionally reduced/low lean body mass compared to excess fat mass, may lead to disability. 
Aims: The aim of our study was to investigate the relationship among sarcopenic obesity, physical 
performance, disability, and quality of life in a rehabilitation setting. Methods: Participants were 
recruited among obese patients (BMI > 30 kg/m2) admitted to the rehabilitation facility at the De-
partment of Experimental Medicine, Medical Physiopatology, Food Science and Endocrinology Sec-
tion during a 1-year period. A multidimensional evaluation was performed through bioelectrical 
impedance analysis and anthropometry, handgrip strength test, Short Physical Performance Bat-
tery (SPPB), 6-minute walk test (6MWT) and blood chemistry parameters. Psychological status 
(SCL-90 questionnaire), quality of life, and comorbidity (Charlson comorbidity index score) were 
also evaluated. Obesity was diagnosed as increased fat mass by 35% in women and by 25% in men. 
Sarcopenia was defined if lean body mass (LBM) was <90% of the subject’s ideal LBM. Results: 79 
patients (48 women and 31 men; mean age: 60.1 ± 11.5 years, and 58.6 ± 10.8 years, respectively) 
were enrolled. Results showed a high prevalence of SO (54.4%) in our samples of obese subjects. 
Sarcopenia was present not only among older obese adults but also among younger obese subjects, 
and was related to reduced functional performance, to inflammatory status and to worse psycho-
logical status and quality of life. 
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1. Introduction 
Sarcopenic obesity is a critical public health related to two important phenomena: the rising prevalence of obes-
ity in western and developing countries, and the increase of lifespan [1]-[4]. Changes in body composition, oc-
curring in ageing as well as in obesity, represent the common soil where sarcopenic obesity develops [4].  
A wealth of studies have focused on the reduction of lean body mass (LBM) in the elderly, that is simulta-
neously accompanied by the increase of the fat mass percentage, even when body weight and body mass index 
(BMI) remain stable [5]-[10]. The above mentioned changes in body composition associated with the ageing 
process have been demonstrated to occur also in obesity [5]-[10] (Figure 1). An imbalance between lean mass, 
excess body fat and total body size may appear earlier in obese adults [5] [6], because of the disproportion be-
tween the even conserved lean mass when compared to fat mass, exceeding body weight that lean mass could 
support. 
Likewise, both sarcopenia and obesity are linked to functional impairment [11] [12]. Moreover, the associa-
tions between obesity per se and poor physical performance, as well as long-term consequences of sarcopenia on 
physical performance are potentially more severe in obese elder individuals [13]-[15]. 
Diagnostic criteria for sarcopenic obesity are not universally established, and different definitions are cur-
rently available. Hence, sarcopenic obesity prevalence ranges from 2.75% to over 20%, depending on the crite-
ria used for the diagnosis and methods of body composition assessment [6] [16]. Moreover the pathogenetic and 
functional role of sarcopenia or “relative” sarcopenia in obese elderly subjects as well as in younger adults, re-
mains to be better clarified. 
The aim of our study was to investigate the relationship among sarcopenic obesity, physical performance, 
disability, and quality of life. 
2. Methods 
2.1. Subjects 
Participants were recruited among all obese patients admitted to the rehabilitation facility at the Department of 
Experimental Medicine—Medical Physiopatology, Food Science and Endocrinology Section—from January to  
 
 
Figure 1. Sarcopenic obesity pathogenesis. Legend: IMAT = intramuscular adipose tissue.                         
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December 2011. Inclusion criteria were: age ≥ 18 years; fat mass > 25% in men and >35% in women; exclusion 
criteria were: sarcopenia associated to cancer cachexia or neurological diseases (CNS diseases), any malignant 
disease during the last five years, inflammatory myopathies, corticosteroids for systemic use, growth hormone 
replacement therapy, testosterone replacement therapy in males, sex hormone replacement therapy in females, 
bedridden subjects. All the evaluations (body composition, functional, health, disability and quality of life as-
sessments, laboratory data) were performed during the first week after admission by a physician skilled in clini-
cal nutrition.  
The study was performed after the approval of the local ethics committee. Oral and written informed consent 
was obtained from all the participants. 
2.2. Body Composition 
Anthropometric measurements were taken following standardized procedures in accordance with the “Anthro-
pometric standardization reference manual” by Lohman et al. [17]. Body weight was measured to the nearest 0.1 
kg through a standard column body scale (SECA, Hamburg, Germany). Body height was determined using a 
rigid stadiometer (SECA, Hamburg, Germany) to the nearest 0.1 cm. Body mass index (BMI) was calculated as 
body weight in kg/(body height in m)2.  
Body composition [fat mass (FM) and LBM] was estimated by bioelectrical impedance analysis (BIA). The 
BIA measurement was performed following a standardized protocol (BIB) on the right side of the body using 
800-A and 50-kHz alternating sinusoidal current and a standard tetrapolar technique (BIA 101 Impedance Ana-
lyzer, AKERN, Florence, Italy). Body composition was assessed through the Lukaski equation validated in 
obese subjects [18]. 
Lean body mass index (LBMI) was calculated as LBM in kg/(body height in m)2. 
2.3. Diagnosis of Obesity and Sarcopenia 
Obesity was diagnosed as fat mass increased by 35% in women and by 25% in men [19] [20]. LBM was consi-
dered depleted if it was <90% of subject’s ideal LBM (iLBM). Taking into account that fat mass in normal 
weight subjects corresponds to 15% in men and 25% in women [19] [20], ideal LBM was calculated in kg as the 
sum of 85% of ideal body weight in men or 75% in women, plus 25% of excess weight, expressed as body 
weight exceeding a reference body weight corresponding to a BMI > 25 kg/m2, considering that excess body 
weight includes not only fat mass but also a certain amount of muscle mass [21] [22].  
2.4. Physical Function Assessment 
The hand-grip strength test (HGST) using the JAMAR Hydraulic Hand Dynamometer (Lafayette Instrument 
Company, USA), the Short Physical Performance Battery (SPPB), and the 6-minute walk test (6MWT) were 
performed in order to assess physical function and mobility [23]-[25]. Cut off values for HGST were <20 kg for 
women and <30 kg for men [26], while physical performance was considered impaired when total SPPB score 
was ≤8 [26]. The 6-minute walked distance (6MWD) was compared to the predicted total distance walked dur-
ing six minutes, computed using reference equations for the Italian population by Chetta et al. [27]. 
2.5. Health, Disability and Quality of Life Assessment 
The collection of medical history and physical examination, as well as questionnaire administration, were per-
formed on admission. Comorbid conditions were assessed using the Charlson comorbidity index score [28]. 
Disability was evaluated using the test for obesity-related disabilities (TSD-OC test) by the Italian Society of 
Obesity [29]. Quality of life was assessed by the administration of the Short-Form Health Survey questionnaire 
(SF-36 questionnaire) [30], and anxiety and depression were measured using the Symptom Checklist-90 (SCL- 
90 questionnaire) [31].  
2.6. Laboratory Data 
Blood samples were obtained from the antecubital vein; blood sampling was performed in the early morning af-
ter an overnight fasting. 
L. M. Donini et al. 
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Albumin, prealbumin, transferrin, hemoglobin, blood cell count and lymphocyte count, high-sensitivity 
C-reactive protein (HS-CRP), and cholinesterase levels were tested using commercial kits supplied by ABX Ita-
ly (Rome).  
2.7. Statistical Analysis 
After the verification of the normal distribution of the continuous variables, parametric tests were used to eva-
luate the difference between sarcopenic obese and nonsarcopenic obese subjects. The independent t-test was 
performed to describe differences between means of the groups. A linear regression analysis was performed to 
verify the association between body composition parameters (FM, LBM, real LBM/ideal LBM ratio) and clini-
cal, functional and biochemical parameters.  
Differences were considered to be statistically significant for p < 0.05. Statistical analysis was performed us-
ing SPSS 10.0 statistical software (SPSS Inc Wacker Drive, Chicago, IL, USA). 
3. Results 
A total of 79 subjects—48 women and 31 men—were enrolled in the study. They represent all the subjects ad-
mitted to the rehabilitation unit during the observation period. Mean age was: 60.1 ± 11.5 years for women and 
58.6 ± 10.8 years for men respectively. Age and BMI were not statistically significantly different between gend-
ers, whereas statistically significant differences were found in terms of body composition (fat mass, LBM, 
LBMI and real LBM/ideal LBM ratio) as well as functional performance (handgrip strength test and SPPB score) 
and biochemical parameters (hemoglobin, lymphocytes, transferrin, albumin, prealbumin, cholinesterase levels), 
globally showing decreased values in females. No difference was observed with respect to depression, anxiety, 
quality of life, TSD-OC test score, HS-CRP, 6MWD, 6MWD/predicted-6MWD, and clinical status expressed by 
the Charlson comorbidity index (Table 1). 
According with the definition used for diagnosing sarcopenia (real LBM/ideal LBM ratio < 0.9), 43 (54.4%) 
obese subjects were sarcopenic. Sarcopenic obese subjects were older (mean age: 60.9 ± 10.3 versus 57.8 ± 11.0 
years; p < 0.05); in particular, in our study population prevalence of sarcopenia was 52.9% in subjects aged less 
than or equal to 65 years and 57.1% in subjects older than 65 years (p = 0.314). Sarcopenic obese subjects had a 
reduced BMI (44.2 ± 6.2 versus 46.9 ± 8.3 kg/m2; p < 0.05) due to the observed significant reduction of LBM 
(both total LBM—expressed in kg—and LBMI were significantly reduced) and, to a lesser extent, to a de-
creased amount of FM, when compared to their non-sarcopenic obese counterparts. Functional parameters (in 
particular hand grip strength and disability) were significantly reduced (p < 0.05), while a trend toward de-
creased values, but no statistically significant difference, was found for 6MWD and SPPB score, confirming a 
lower functional capacity in sarcopenic obese subjects. Concerning clinical and laboratory parameters, signifi-
cant differences were found just for hemoglobin and albumin, that were significantly reduced in sarcopenic ob-
ese subjects, while their HS-CRP levels were significantly higher than nonsarcopenic obese subjects (p < 0.05). 
Quality of life (in particular physical health-related quality of life), expressed by the SF-36 questionnaire score, 
was significantly impaired, while depression, anxiety and SCL-90 questionnaire total score were significantly 
increased in sarcopenic obese subjects when compared to nonsarcopenic obese subjects (Table 2). 
In Table 3 the correlation between real LBM/ideal LBM ratio and clinical, functional and laboratory parame-
ters is described. A negative significant correlation was found with age, disability (TSD-OC test), HS-CRP and 
depression score at the SCL-90 questionnaire. A positive significant correlation was found between real 
LBM/ideal LBM ratio and BMI, handgrip strength, functional performance (SPPB score), hemoglobin, serum 
transport proteins (albumin, transferrin, and prealbumin), and quality of life (physical health-related quality of 
life and SF-36 questionnaire total score). 
Table 4 shows the correlation between different parameters defining fat mass (FM as percentage of body 
weight, total FM in kg, and FMI) and lean body mass (LBM as percentage of body weight, total LBM in kg, and 
FMI) and functional parameters. LBM was positively correlated with handgrip strength and SPPB score, and 
negatively correlated with disability (TSD-OC test score) (p < 0.05).  
On the contrary, FM was negatively correlated with SPPB score, and positively correlated with disability 
(TSD-OC test score) (p < 0.05). No correlation was found between FM and handgrip strength, and between FM 
and LBM with the distance walked at the 6MWT. 
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Table 1. Demographic characteristics and anthropometric parameters of the study population.                          
 Women Men p 
No. of subjects 48 31  
Age (years) 60.1 ± 11.54 58.6 ± 10.8 NS 
Anthropometric parameters 
BMI (kg/m2) 45.6 ± 7.5 45.1 ± 7.5 NS 
Fat mass (kg) 53.2 ± 10.8 58.8 ± 15.2 NS 
Fat mass (%) 47.5 ± 3.6 43.3 ± 4.8 * 
Lean body mass (kg) 51.8 ± 8.1 74.5 ± 12.7 * 
Lean body mass index (kg/m2) 21.2 ± 3.2 25.0 ± 3.7 * 
Real LBM/ideal-LBM 0.88 ± 0.01 0.95 ± 0.1 * 
Functional parameters 
Handgrip strength test (kg) 16.9 ± 7.0 30.1 ± 11.1 * 
6-minute walk test distance (m)§ 216.9 ± 101.1 261.6 ± 136.8 NS 
6MWT distance/predicted-6MWT distance§ 0.7 ± 0.3 0.7 ± 0.4 NS 
SPPB score 7.5 ± 2.7 9.2 ± 2.3 * 
TSD-OC test (score-%) 65.9 ± 21.4 59.2 ± 23.6 NS 
Clinical and laboratory parameters 
Charlson comorbidity index 2.3 ± 2.1 2.6 ± 1.9 NS 
Hemoglobin (g/dl) 11.9 ± 1.1 13.7 ± 1.7 * 
Lymphocytes (#/ml) 1992.2 ± 740.6 2371.5 ± 877.4 * 
Transferrin (mg/dl) 242.6 ± 55.4 267.3 ± 44.3 * 
Albumin (g/dl) 3.7 ± 0.2 4.1 ± 0.3 * 
Prealbumin (mg/dl) 20.4 ± 5.4 24.9 ± 6.9 * 
Cholinesterase (U/l) 7903.7 ± 1851.0 9033.0 ± 1773.4 * 
C-reactive protein-HS (mg/dl) 7.8 ± 6.0 6.7 ± 7.0 NS 
Depression, anxiety and quality of life 
SCL-90 questionnaire 
Depression 1.2 ± 0.9 1.0 ± 0.9 NS 
Anxiety 1.4 ± 0.9 1.1 ± 1.0 NS 
Total score 95.0 ± 64.9 88.8 ± 60.4 NS 
SF-36 questionnaire 
MHI 31,6 ± 17.8 32.4 ± 21.6 NS 
PHI 28.2 ± 17.2 32.1 ± 18.6 NS 
Total score 29.9 ± 16.9 33.0 ± 20.0 NS 
Legend: BMI: body mass index; LBM: fat free mass; 6MWT: six minutes walk test; SPPB: short physical performance battery; TSD-OC: Italian so-
ciety of obesity test for obesity-related disabilities; SF-36: short-form health survey questionnaire; SCL-90: symptom checklist-90. §18/48 women 
(37.5%) and 12/31 men (38.7%) did not complete the 6MWT due to cardiovascular, respiratory or osteoarticular problems. *p < 0.05; NS: not statisti-
cally significant. 
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Table 2. Clinical, functional and laboratory parameters and subjects’ characteristics related to real LBM-real/ideal LBM ra-
tio.                                                                                                   
 
Real LBM/ideal LBM ratio p 
≥0.9 <0.9  
Subjects (n) 36 43  
Age (years) 57.8 ± 11 60.9 ± 10.3 * 
Anthropometric parameters 
BMI (kg/m2) 46.9 ± 8.3 44.24 ± 6.2 * 
FM (%) 45.4 ± 4.8 46.3 ± 4.1 NS 
FM (kg) 58.6 ± 14.6 52.9 ± 10.5 * 
LBM (kg) 70.9 ± 16.2 52.9 ± 9.4 * 
LBMI 25.7 ± 4 20.4 ± 2.4 * 
Functional parameters 
HGST (kg) 25.8 ± 11.2 18.9 ± 9.3 * 
6MWT distance (m)1,2 159.4 ± 156.5 136.4 ± 126.4 NS 
6MWT distance/predicted-6MWT distance1,2 0.46 ± 0.44 0.42 ± 0.38 NS 
TSD-OC test 55.9 ± 21.9 69.1 ± 20.6 * 
SPPB score 8.5 ± 3.0 7.9 ± 2.4 NS 
Clinical and laboratory parameters 
Charlson comorb index 2.6 ± 2 2.3 ± 2 NS 
Hemoglobin (g/dl) 12.9 ± 1.7 12.2 ± 1.3 * 
Lymphocytes (#/ml) 2157.6 ± 892.3 2100 ± 736.8 NS 
Transferrin (mg/dl) 259.4 ± 55.4 248.2 ± 50.6 NS 
Albumin (g/dl) 3.93 ± 0.3 3.82 ± 0.3 * 
Prealbumin (mg/dl) 23.1 ± 6.8 21.5 ± 5.7 NS 
Cholinesterase (U/l) 8191.1 ± 1718.2 8476.9 ± 1992.2 NS 
CRP-HS (mg/dl) 6.53 ± 7 7.9 ± 5.6 * 
Anxiety, depression and quality of life 
SF-36  
questionnaire 
PHI 31.3 ± 19.1 28 ± 16.1 * 
MHI 32.8 ± 20 31 ± 18.1 NS 
Total score 32.4 ± 19.6 29.8 ± 16.4 * 
SCL-90  
questionnaire 
Depression 0.8 ± 0.9 1.4 ± 0.8 * 
Anxiety 0.9 ± 0.8 1.6 ± 0.9 * 
Total score 76.2 ± 63.8 108.9 ± 59.4 * 
Legend: BMI: body mass index; FM: fat mass; LBM: fat free mass; LBMI: fat free mass index; HGST: handgrip strength; 6MWT: six minutes walk 
test; SPPB: short physical performance battery; TSD-OC: Italian society of obesity test for obesity-related disabilities; SF-36: short-form health sur-
vey questionnaire; SCL-90: symptom checklist-90; CRP: high sensitivity C-reactive protein. Notes: 115/43 non-sarcopenic (34.9%) and 15/36 sarco-
penic (41.7%) did not complete the 6MWT; 218/48 women (37.5%) and 12/31 men (38.7%) did not complete the 6MWT due to cardiovascular, res-
piratory or osteoarticular problems. *p < 0.05; NS: not statistically significant. 
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Table 3. Correlation between real LBM/ideal LBM ratio and clinical, functional and laboratory parameters.               
 Pearson’s r p 
Age (years) −0.21 * 
Anthropometric parameters 
BMI (kg/m2) 0.286 * 
FM (%) −0.09 NS 
FM (kg) 0.321 * 
LBM (kg) 0.782 * 
LBMI 0.895 * 
Functional parameters 
HGST (kg) 0.524 * 
6MWT distance (m)1,2 −0.039 NS 
6MWT distance/predicted-6MWT distance1,2 −0.085 NS 
TSD-OC test −0.367 * 
SPPB score 0.362 * 
Clinical and laboratory parameters 
Charlson comorb index 0.053 NS 
Hemoglobin (g/dl) 0.33 * 
Lymphocytes (#/ml) 0.09 NS 
Transferrin (mg/dl) 0.183 * 
Albumin (g/dl) 0.242 * 
Prealbumin (mg/dl) 0.178 * 
Cholinesterase (U/l) 0.087 NS 
CRP-HS (mg/dl) −0.158 * 
Anxiety, depression and quality of life 
SF-36  
questionnaire 
PHI 0.222 * 
MHI 0.035 NS 
Total score 0.181 * 
SCL-90  
questionnaire 
Depression −0.198 * 
Anxiety −0.132 NS 
Total score −0.056 NS 
Legend: BMI: body mass index; FM: fat mass; LBM: fat free mass; LBMI: fat free mass index; HGST: handgrip strength; 6MWT: six minutes walk 
test; SPPB: short physical performance battery; TSD-OC: Italian society of obesity test for obesity-related disabilities; SF-36: short-form health sur-
vey questionnaire; SCL-90: symptom checklist-90; CRP: high sensitivity C-reactive protein. Notes: 115/43 non-sarcopenic (34.9%) and 15/36 sarco-
penic (41.7%) did not complete the 6MWT; 218/48 women (37.5%) and 12/31 men (38.7%) did not complete the 6MWT due to cardiovascular, res-
piratory or osteoarticular problems. *p < 0.05; NS: not statistically significant. 
 
Table 4. Correlation between body composition (fat mass and free-mass) and functional parameters.                     
 Fat mass Fat free mass 
 FM (%) FM (kg) FMI LBM (%) LBM (kg) LBMI 
HGST (kg) −0.137 −0.155 −0.106 0.357* 0.469* 0.492* 
6MWT (m)1,2 −0.169 −0.079 −0.107 0.072 0.084 0.059 
6MWT distance/predicted-6MWT distance1,2 −0.15 −0.115 −0.104 0.037 0.021 0.115 
TSD-OC test 0.243* 0.234* 0.266* −0.268* −0.253* −0.296* 
SPPB score −0.449* −0.172* −0.394* 0.326* 0.233* 0.331* 
Legend: FM: fat mass; LBM: fat free mass; LBMI: fat free mass index; HGST: handgrip strength; 6MWT: six minutes walk test; SPPB: short physi-
cal performance battery; TSD-OC: Italian society of obesity test for obesity-related disabilities. Notes: 115/43 non-sarcopenic (34.9%) and 15/36 sar-
copenic (41.7%) did not complete the 6MWT; 218/48 women (37.5%) and 12/31 men (38.7%) did not complete the 6MWT due to cardiovascular, 
respiratory or osteoarticular problems. *p < 0.05. 
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4. Discussion  
In the present study we found a high prevalence of sarcopenia (defined as real LBM/ideal LBM ratio) in a sam-
ple of obese subjects. Sarcopenia was present not only among older obese adults, but also in pre-geriatric obese 
subjects. Furthermore, SO was related to reduced functional performance, to inflammatory status, to a worse 
psychological status as well as to reduced quality of life.  
Diagnosis of sarcopenic obesity is a challenging clinical issue. Existing prevalence data are very variable and 
inconsistent because of the use of different methods for diagnosis (see a recent systematic review on this topic 
[32]), and most of the extant studies involved only older adults [5] [16] [26] [33]. In our study we evaluated 
sarcopenia using the ratio between LBM estimated by BIA and the ideal LBM. In our opinion and according 
with our data, the ratio between real LBM and ideal LBM may represent an additional indicator of sarcopenia, 
and a ratio less than 0.9 may be considered indicative of sarcopenia. Anyway, these data need to be confirmed 
by future studies. In accordance with the extant literature about body composition in adult and healthy humans, 
85% in men and 75% in women, respectively, of the normal body weight consists of lean mass. In addition, as 
suggested by a number of studies about body composition and obesity, in obese subjects excess body weight is 
not only made of fat mass, but it includes a certain amount of muscle mass, that seems to correspond to 25% of 
excess body weight [19] [22] [23] [34]-[36]. The augmentation of LBM paralleling the increase of body weight 
would be a protective mechanism allowing the obese individual to sustain the gained fat mass, avoiding, at least 
in the early phases of the process, the onset of metabolic and functional impairment as fat mass increases. In fact, 
on the basis of the above mentioned evidence and our data, we hypothesize that a “relative” sarcopenia, before 
the development of an “absolute” sarcopenia, is predictive of disability in obese subjects. This remark is consis-
tent with observations showing that abnormalities in body composition, affecting lean mass, occur in obese sub-
jects even prior to the old age, overall due to inflammation, dieting and weight cycling phenomena, and en-
gagement in sedentary activities [36]-[39]. Few studies showed that weight regain after weight loss may be at 
the basis of changes in body composition leading, at the end of the cycle, paradoxically to an increased amount 
of body fat [39] [40]. The combination of these mechanisms, the former protective, the latter detrimental to-
wards lean body mass, may account for discrepancies from previous studies; the use of the real LBM/ideal LBM 
ratio may be effective in reducing and overcoming these differences.  
In our study, prevalence of sarcopenia in obese subjects was higher than sarcopenic obesity prevalence re-
ported from available prevalence studies [5] [16] [33]. This finding could be potentially explained by the setting 
of recruitment in our study: all the subjects were enrolled in a rehabilitation unit devoted to the nutritional and 
metabolic rehabilitation of subjects with obesity or eating disorders. Clinical status and disability in our study 
population were consistent with a more deteriorated clinical condition and functional performance, even if many 
obese participants were younger than 65 years. Another potential explanation may be related to the normative 
value that we used (real LBM/ideal LBM ratio < 0.9). This cut-off needs to be verified in a larger sample of ob-
ese subjects. However, the correlation found in our study between real LBM/ideal LBM ratio and functional pa-
rameters let us argue that this value is sufficiently correct. 
In the present study disability was assessed through the TSD-OC test, a recently validated tool specifically 
designed to assess disability level in obese subjects [29]. The TSD-OC test is composed of 36 items divided into 
seven sections (pain, stiffness, activities of daily living and indoor mobility, housework, outdoor activities, oc-
cupational activities and social life). In the validation study the TSD-OC test was found to be significantly cor-
related to functional assessment (6MWD and handgrip strength) and quality of life parameters (SF-36 question-
naire). Our results highlight that the presence of sarcopenia in obese subjects was associated with a worse 
TSD-OC test score; this finding is consistent with data provided by a recent study by Baumgartner, pointing out 
the coexistence of low physical capacity and sarcopenic obesity [10]. These observations support the synergic 
pathological action exerted by obesity and sarcopenia; however, it is still matter of debate which of the two 
components (increased FM or reduced LBM) in sarcopenic obesity is better correlated with disability. Different 
studies concluded that excess body fat was a stronger contributor to physical function impairment than sarcope-
nia [41] [42]. Davison and coll. did not demonstrate any association between sarcopenia and functional limita-
tions, instead mobility impairment was related to percentage of body fat and BMI [13]. Similarly, Cawthon et al. 
found that adipose tissue and performance status were more closely related to disability than lean body mass 
[43]. 
In our study, decreased LBM and increased FM were independently and statistically significantly associated 
with different functional parameters suggesting that both sarcopenia and obesity account for disability. The ef-
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fect of fat mass on physical function is under debate and some Authors consider that it may be as great as that of 
muscle mass, accounting for the U-shaped relationship between BMI and physical limitations [44]. In our study 
the correlation was stronger for LBM and especially for the real LBM/ideal LBM ratio. We stress the need for a 
more precise assessment of body composition, taking into account the role of sarcopenia as a pivotal determi-
nant of disability in obese subjects. Few studies tried to consider the effect of both fat mass and lean body mass 
on disability. In a recent paper, Authors hypothesized that disability caused by sarcopenia and sarcopenic obesi-
ty was related to the amount of adiposity or body weight bearing on a unit of muscle mass (total body fat to 
lower limb muscle mass ratio) [45]. Our finding of increased disability in obese subjects with sarcopenia con-
firms that the sarcopenia, in the context of obesity, may be better defined as a “relative” sarcopenia: despite the 
appearance that muscle mass is conserved, it probably is not enough in proportion to the total body mass to pre-
vent the onset of functional impairment and disability. Moreover, fat infiltration of muscles, named “myosteato-
sis” [46], could also be responsible for deteriorated muscle strength in obese individuals. Changes in body com-
position and musche strength related to the ageing process and in particular to changes in body composition are 
associated with functional decline [47]. 
One of the more significant findings emerging from our study is that sarcopenia was found also in relatively 
young obese subjects. Papers reporting analogous data are scarce [48]. In line with the hypothesis that obesity 
produces low-grade inflammation and hormonal changes affecting muscle function and metabolism, obese 
young people could have similar changes and meet the criteria for the diagnose of sarcopenic obesity [48]. 
Moreover pronounced and prolonged inactivity together with repeated unbalanced diets leading to rapid weight 
loss may deeply affect lean body mass. 
One limitation to our study was the use of BIA in order to assess muscle mass, that is less precise than DXA 
or other imaging methods like magnetic resonance or CT-scan. On the other hand, as in most of the clinical fa-
cilities, in our rehabilitation unit DXA scanner machine held a maximum body weight of 130 kg, and it would 
have made impossible the DXA analysis of the severely obese participants, who are usually the most represented 
obese individuals in our metabolic-nutritional-psychological rehabilitation unit. However, in line with EWGSOP 
recommendations, BIA is an alternative to expensive imaging techniques, when performed under standard con-
ditions [26] [32] [49]-[51]. Moreover considering 35% and 25%, respectively for males and females, as the cut 
off point of FM to define obesity does not take into account age related changes. However the data in the litera-
ture, similarly to what happens for BMI, do not allow a more precise definition of obesity based on FM and age 
classes. At last the sample size is limited and do not allow a more in depth evaluation for confounders through 
complex models as it would be appropriate in a cross-sectional study. 
Finally, we are aware that an exhaustive definition of sarcopenia needs a thorough evaluation considering 
body composition, muscle strength and physical performance. Our study may be a first step to better define 
LBM depletion in sarcopenic obesity.  
5. Conclusions 
To conclude, sarcopenia (defined through real LBM/ideal LBM ratio) in obese subjects seems to be correlated to 
disability, reduced functional performance, worse psychological status and reduced quality of life. Further re-
search should be prompted: 
-in order to confirm the validity of the proposed definition of sarcopenia adapted to obese subjects, focusing 
on muscle quality and composition; 
-to define specific nutritional, psychological, and functional rehabilitation programs for sarcopenic obese 
subjects, aimed at modifying body composition (increasing LBM while decreasing FM) and improving func-
tional parameters and quality of life [52]. 
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